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Autoimmune limbic encephalitis (LE) is a rare disorder affecting the
medial temporal lobe of the brain [1]. Previous studies have identified
neuronal antibodies as possibly being involved in the pathogenesis of
LE, reacting either against intracellular antigens including Hu (a neuron-
specific family of RNA binding proteins), crossveinless-2/collapsing
response mediated protein 5 (CV2/CRMP5), paraneoplastic Ma antigen
2 (Ma2), and amphiphysin or against cell membrane antigens such as
voltage-gated potassium channels, N-methyl-D-aspartate receptors
(NMDAR), and glutamic acid decarboxylase (GAD) [2].A few studies reported 2-deoxy-2-[18F]fluoro-D-glucose positron
emission tomography/computed tomography (18F-FDG PET/CT) find-
ings in patients with LE, typically consisting of metabolic abnormalities
more prominent in the temporal lobes, often correlating with
symptoms of limbic dysfunction. In particular, three different patterns
have been described in literature: (a) the first one (mixed hyper-
hypometabolic) is characterized by the striking disparity between
temporal hypermetabolism and occipital hypometabolism [3]; (b) the
second one is indistinguishable from advanced Alzheimer’s disease
with diffuse moderately tomarkedly reducedmetabolism in the cortex,
more prominent in the posterior temporal lobes, with sparing of the
visual cortex and primary sensorimotor strips [1]; (c) the third one,
very similar to themixed hyper-hypometabolic pattern, is characterized
by focal hypermetabolism in the medial temporal lobes and mainly
reported in patients with paraneoplastic autoimmune encephalitis [4].
Here, we present two cases of LE with unusual brain metabolic
patterns evidenced by 18F-FDG PET/CT.2. Report of the cases
2.1. Case 1: hyper-hypometabolic pattern with double antibody positivity
A 23-year-old woman was referred for the sudden onset of a
psychosis-like syndrome, characterized by severe agitation, bizarre
Fig. 1. 18F-FDG PET/CT and SPM analysis of patient number 1 showing hypermetabolism in the lateral parietotemporal cortex bilaterally, orbitofrontal cortex (more pronounced
in left hemisphere), globus pallidi, midbrain, brainstem, cerebellar tonsillae, and culmen and areas of hypometabolism in the primary visual cortex, associative visual cortex, and
posterior cingulus.
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No previous major traumatic, neurological, or psychiatric disease was
present in the remote clinical history. The history was negative for
smoking, alcohol, and substance abuse. Only cephalea and reduction
of the sleep time were reported in the last few days.
The patient underwent a brain CT without contrast, which did not
show any abnormalities. Standard blood tests were normal. Due to
rapid worsening of the cognitive state and onset in the following 2
days of generalized epilepsy, dyskinesia of the left side of the face,
and left gaze deviation, another brain CT was performed but did not
show any pathological finding. Exams for various neurotropic viruses
including herpes simplex virus (HSV), hepatitis C virus, human
immunodeficiency virus, and cytomegalovirus; bacteria (such as
Klebsiella pneumoniae and methicillin-resistant Staphylococcus aureus);and toxic metabolites (mercury, manganese, lead, and aluminum)
were all negative. Serial electroencephalogram (EEG) examinations
did not show abnormalities.
A brain magnetic resonance imaging (MRI) with T1- and T2-
weighted, fluid-attenuated inversion-recovery (FLAIR) and diffusion-
weighted (DW) images revealed mild hyperintensities in the left
temporomesial region, in the parahippocampal circonvolution, and in
the posterior side of the uncus, consistent with LE.
Due to the severity of the clinical scenario, an empiric therapy with
fentanyl, midazolam, acyclovir, ceftriaxone, and ampicillin was started.
A week later, a further brain MRI showed disappearance of the
previously detected imaging findings. After 2 weeks, a third brain MRI
showed diffuse abnormal signals in right temporal cortex, in bilateral
frontal and occipital regions, and in basal ganglia.
Fig. 2. A first 18F-FDG brain PET/CT. Transaxial images revealed hypometabolism in temporomesial regions (more prominent on the right side), posterior cingulate, and left precuneus.
Fused transaxial images.
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bodies directed against the anti-voltage-gated potassium channels (VOKC),
alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) recep-
tors 1 and 2, gamma-aminobutyric-acid B (GABA-B) receptor and GAD, and
NMDARand foronconeuronal antibodiesdirectedagainst intracellularneuro-
nal antigens (Hu, Yo, Ri, CV2/CRMP5, amphiphysin, Ma1, Ma2/Ta antigens).
Cerebrospinal fluid (CSF) analysis showed hypercellularity with
elevated IgG and mild positivity to anti-GAD and -NMDAR, without
any clear triggering factor. Two further brainMRI examswere performed
after 2 weeks and 1 month, respectively, and resulted negative.
Due to the suspicion of a paraneoplastic encephalitis, the patient
underwent also a CT scan of the brain, chest, and abdomenwith contrast
medium, which did not show any abnormalities.
The patient then underwent a PET/CT study using a Discovery ST-E
scanner (General Electric Medical System, Milwaukee, WI, USA)
60min after injection of 185MBq of 18F-FDG. Semiquantitative analysis
using Statistical Parametric Mapping (SPM) (SPM2, Wellcome Depart-
ment of Cognitive Neurology, London, UK), implemented in Matlab 6.5
(Mathworks, Natick, MA, USA), was performed.
Visual and SPM analysis detected hypermetabolism in the lateral
parietotemporal cortex bilaterally, orbitofrontal cortex (more pro-
nounced in left hemisphere), pallidus, midbrain, brainstem, cerebellar
tonsillae, and culmen. Areas of hypometabolismwere evidenced in pri-
mary visual and associative visual cortex and posterior cingulus (Fig. 1).
The imaging pattern, depicting most of the hypermetabolic areas,
in keeping with presence of GAD and NMDAR autoantibodies (whose
triggering factor remained explained), confirmed a possible diagnosis
of autoimmune encephalitis, in keeping with the immunological essay
(mild positivity to anti-GAD and anti-NMDAR antibodies).2.2. Case 2: migrating foci of hypermetabolism
A 52-year-oldwomanwas referred to our departmentwith suspected
LE. The patient was slightly confused but otherwise asymptomatic.
Brain MRI, with FLAIR and DW sequences, showed areas of
hyperintensities of a limited extent inmany areas andwithout significant
abnormality on the spectroscopy, consistent with inflammatory lesions.
Antibodies directed against the VOKC, AMPA receptors 1 and 2, GABA-B
receptor and GAD, and NMDAR and for onconeuronal antibodies
directed against intracellular neuronal antigens (Hu, Yo, Ri, CV2/CRMP5,
amphiphysin,Ma1,Ma2/Ta antigens) resulted negative in CSF and serum.
Also, a total body 18F-FDG (140 MBq) PET/CT excluded underlying
paraneoplastic syndrome. The brain scan showed hypometabolism in
temporomesial region, more prominent on the right side and also in-
volving posterior cingulate and left precuneus (Fig. 2). Therefore, the
patient underwentmedical therapy with corticosteroids, levetiracetam,
and phenobarbital.
Six months later, the patient underwent a follow-up brain MRI,
whose findings were unchanged, and an 18F-FDG brain PET/CT. The
areas of hypometabolism were still present, but there was evidence of
a hypermetabolic focus in the left temporal lobe not present at the
first examination (Fig. 3). EEG, performed at injection, was negative.
The therapy was continued and, 1 month later, the patient
underwent a third MRI, still unchanged, and a third 18F-FDG brain
PET/CT. Again, the hypometabolic areas were still present, but there
was the evidence of another hypermetabolic focus in the right
temporomesial region (Fig. 4). At this time, the previously described
hypermetabolic focus in the left temporal lobe showed reduced
glucose metabolism.
Fig. 3. Two sequential 18F-FDG brain PET/CTs, transaxial view. The first examination does not show any hypermetabolic area (A), which appears on the follow-up (B) in the left temporal
lobe. The color scale has been toned up in order to evidence the relative intense hypermetabolism in the affected area.
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partially relieved by the ongoing therapy.
3. Discussion
The diagnosis of LE represents a clinical challenge, and previous
reports show a huge variability in the neuroimaging findings [1–4].
Brain MRI usually shows, at FLAIR images or T2 sequences, hyperin-
tense signal in the medial part of the temporal lobes, which is often
asymmetric or unilateral [1]. Additionally, 18F-FDG PET/CT can reveal
abnormalities in other areas such as brainstem, cerebral cortex, or
cerebellum, some of them clinically silent [5].
Our first patient, despite two negative follow-up MRI exams,
presented an uncommon 18F-FDG brain mixed metabolic pattern as
described by Fisher [2] showing hypometabolism involving the primary
visual cortex, left associative visual cortex, left parahippocampal
gyrus, and thalamus, associated with hypermetabolic foci in lateral
parietotemporal cortex bilaterally, orbitofrontal cortex, cerebellar
tonsillae, and culmen. However, in this patient, 18F-FDG PET/CT docu-
mented few additional findings including increased metabolism in
pallidus, midbrain, and brainstem. Whereas basal ganglia [6] as well as
brainstem [5] hyperactivity has been separately demonstrated, this is
the first time that midbrain hypermetabolism is documented in a
patient affected by autoimmune encephalitis. MRI abnormalities in
midbrain along with imaging abnormalities in medial temporal lobes
have been reported in case of LE related to antibodies against Ma2(a protein playing a role in the biogenetic pathway of messenger RNA
and hyperexpressed in patients with various types of tumors) [7].
However, there are no reports regarding increased FDG uptake in the
midbrain of such patients. Another peculiarity of our first case is the
positivity to two different types of antibodies (GAD and NMDAR auto-
antibodies), unlike many previous reports.
Moreover, to the best of our knowledge, only one case of autoim-
mune encephalitis analyzed by SPM has been reported in literature
[8]. Finally, in our patient, MRI evidenced fluctuating signs. In particular,
a week after the start of therapy, MRI was negative, but 2 weeks later, it
showed diffuse abnormalities (right temporal cortex, bilateral frontal
cortex, occipital regions, and basal ganglia).
The second patient presented areas of brain hypometabolism in-
volving temporomesial regions, posterior cingulate, and precuneus
not correlating with any clinical symptom. The further sequential
18F-FDG PET/CTs surprisingly showed migrating foci of hyper-
metabolism, one of which turned into hypometabolism at a
later examination.
FDG hypermetabolism converting to hypometabolism on a follow-
up examination has already been described, but in a case of herpetic
encephalitis [9]. Anyway, this possibility has been excluded in our
patient by HSV serology, and a possible epileptic activity was excluded
as well. The lack of evident antibodies also seems to exclude an
autoimmune-mediated locally increased neuronal activity caused
by direct alteration of synaptic and neuronal properties. Therefore,
it could be reasonably maintained that these hypermetabolic
Fig. 4.On the third follow-up 18F-FDG brain PET/CT, the previously noted hypermetabolic focus is not evident anymore and turned into hypometabolism (yellow arrow). There is evidence
of a new hypermetabolic focus in the right temporal lobe (red arrows). The color scale has been toned up in order to evidence the relative intense hypermetabolism in the affected area.
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could not be properly explained and which have never been
described before.
The absence of any antibodies in our second case represents an un-
usual finding and may indicate a subtype of LE whose response to ther-
apy appears to be partial and more similar to what was observed in
patients without antibodies directed toward cell membrane antigens.
This seems to be in contrast to what was observed by Bataller et al.
[10], who described three patientswith LE of unclear etiology orwithout
antibodies showing an optimal response to corticosteroids. It could be
hypothesized that a further still-unknown cause underlies the onset of
migrating brain inflammatory process. 18F-FDG PET/CT demonstrated
great specificity in the detection of inflammatory areas and was
also more useful than MRI in evaluating therapy response in the
second patient.
In conclusion, we support the use of 18F-FDG brain PET/CT in the
management of patients with LE. Some atypical metabolic patterns,
such as the ones described in our cases, should be recognized and not
confused with cerebral metastases, as it might be suspected in the
presence of a paraneoplastic syndrome.References
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